Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Emad F Youssef"'
Autor:
Michael E, Scheurer, Renke, Zhou, Mark R, Gilbert, Melissa L, Bondy, Erik P, Sulman, Ying, Yuan, Yanhong, Liu, Elizabeth, Vera, Merideth M, Wendland, Emad F, Youssef, Volker W, Stieber, Ritsuko R, Komaki, John C, Flickinger, Lawrence C, Kenyon, H Ian, Robins, Grant K, Hunter, Ian R, Crocker, Samuel T, Chao, Stephanie L, Pugh, Terri S, Armstrong
Publikováno v:
Neuro-oncology advances. 4(1)
We sought to identify clinical and genetic predictors of temozolomide-related myelotoxicity among patients receiving therapy for glioblastoma.Patients (23% of patients developed myelotoxicity (Myelotoxicity during concurrent chemoradiation with temoz
Autor:
Michael E Scheurer, Renke Zhou, Mark R Gilbert, Melissa L Bondy, Erik P Sulman, Ying Yuan, Yanhong Liu, Elizabeth Vera, Merideth M Wendland, Emad F Youssef, Volker W Stieber, Ritsuko R Komaki, John C Flickinger, Lawrence C Kenyon, H Ian Robins, Grant K Hunter, Ian R Crocker, Samuel T Chao, Stephanie L Pugh, Terri S Armstrong
Publikováno v:
Neuro-Oncology Advances. 4
Background We sought to identify clinical and genetic predictors of temozolomide-related myelotoxicity among patients receiving therapy for glioblastoma. Methods Patients (n = 591) receiving therapy on NRG Oncology/RTOG 0825 were included in the anal
Autor:
Deborah T. Blumenthal, Wenyin Shi, Mark R. Gilbert, Egils Valeinis, Molly Scannell Bryan, Nathalie Lessard, James J. Dignam, S.P. Howard, Luis Souhami, Maria Werner-Wasik, David W. Andrews, Emad F. Youssef, Kirsten Hopkins, Paul D. Brown, Minesh P. Mehta, Tzahala Tzuk-Shina
Publikováno v:
Translational Cancer Research
Purpose To determine the impact on overall survival with different salvage therapies, including no treatment, reirradiation, systemic therapy, or radiation and systemic therapy, in participants of a phase 3 clinical trial evaluating dose-dense versus
Autor:
R.A. Rabinovitch, Arnab Chakravarti, Susan M. Chang, Erica Hlavin Bell, Joseph Bovi, Emad F. Youssef, Steven P. Howard, W.A. Yung, Jean-Paul Bahary, Y. Chen, Helen A. Shih, Jessica Fleming, Peixin Zhang, Grant K. Hunter, Joseph P. McElroy
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 102:S46-S47
Autor:
Kenneth J. Levin, Emad F. Youssef, Andrew E. Sloan, Rajiv Patel, Rana K. Zabad, Lucia Zamorano
Publikováno v:
Journal of Neurosurgery. 97:663-665
Object. Recent studies have suggested a high incidence of cognitive deficits in patients undergoing high-dose chemotherapy, which appears to be dose related. Whole-brain radiotherapy (WBRT) has previously been associated with cognitive impairment. Th
Autor:
Emad F, Youssef
Publikováno v:
The Journal of the Arkansas Medical Society. 105(3)
Autor:
Tzuk-Shina Tzahala, Kirsten Hopkins, Egils Valeinis, Luis Souhami, Deborah T. Blumenthal, James J. Dignam, Paul D. Brown, Minesh P. Mehta, Wenyin Shi, Maria Werner-Wasik, Nathalie Lessard, David W. Andrews, Emad F. Youssef, S.P. Howard, Molly Scannell Bryan, Mark R. Gilbert
Publikováno v:
Neuro-Oncology. 17:v8.1-v8
BACKGROUND: There is limited evidence regarding which salvage treatment approach may be of most benefit for glioblastoma patients who progress following standard chemo-radiation treatment. METHODS: This secondary analysis of RTOG 0525 investigated th
Autor:
Kenneth J, Levin, Emad F, Youssef, Andrew E, Sloan, Rajiv, Patel, Rana K, Zabad, Lucia, Zamorano
Publikováno v:
Journal of neurosurgery. 97
Recent studies have suggested a high incidence of cognitive deficits in patients undergoing high-dose chemotherapy, which appears to be dose related. Whole-brain radiotherapy (WBRT) has previously been associated with cognitive impairment. The author